These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 8895684
1. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase. Okada K, Ueshima S, Takaishi T, Yuasa H, Fukao H, Matsuo O. Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684 [Abstract] [Full Text] [Related]
2. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin. Lee AY, Fredenburgh JC, Stewart RJ, Rischke JA, Weitz JI. Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822 [Abstract] [Full Text] [Related]
3. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin. Lijnen HR, Van Hoef B, Matsuo O, Collen D. Biochim Biophys Acta; 1992 Jan 09; 1118(2):144-8. PubMed ID: 1730031 [Abstract] [Full Text] [Related]
4. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex. Okada K, Nonaka T, Matsumoto H, Fukao H, Ueshima S, Matsuo O. Thromb Res; 1994 Oct 15; 76(2):211-20. PubMed ID: 7863470 [Abstract] [Full Text] [Related]
5. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin. Liu JN, Gurewich V. J Clin Invest; 1991 Dec 15; 88(6):2012-7. PubMed ID: 1836471 [Abstract] [Full Text] [Related]
6. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions. Wu JH, Diamond SL. Thromb Haemost; 1995 Aug 15; 74(2):711-7. PubMed ID: 8585011 [Abstract] [Full Text] [Related]
7. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin. Silence K, Collen D, Lijnen HR. J Biol Chem; 1993 May 05; 268(13):9811-6. PubMed ID: 7683664 [Abstract] [Full Text] [Related]
9. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma. Silence K, Collen D, Lijnen HR. Blood; 1993 Aug 15; 82(4):1175-83. PubMed ID: 7688990 [Abstract] [Full Text] [Related]
10. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis. Collen D, Lijnen HR, Vanderschueren S. Verh K Acad Geneeskd Belg; 1995 Aug 15; 57(3):183-96; discussion 196-8. PubMed ID: 7483814 [Abstract] [Full Text] [Related]
14. Mechanism of action and thrombolytic potential of staphylokinase. Lijnen HR. Verh K Acad Geneeskd Belg; 1995 Aug 15; 57(4):303-14. PubMed ID: 8571666 [Abstract] [Full Text] [Related]
15. Inhibitory effect of staphylokinase on platelet aggregation. Suehiro A, Oura Y, Ueda M, Kakishita E. Thromb Haemost; 1993 Nov 15; 70(5):834-7. PubMed ID: 7510426 [Abstract] [Full Text] [Related]
16. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin. Okada K, Yuasa H, Hagiya Y, Fukao H, Ueshima S, Matsuo O. Thromb Res; 1994 Oct 15; 76(2):181-91. PubMed ID: 7863467 [Abstract] [Full Text] [Related]